基于RNAi的药物设计:考虑和未来的方向
Qi Tang1,2, Anastasia Khvorova3,4
1RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Nature reviews. Drug discovery
|April 3, 2024
概括
使用小干扰RNA (siRNA) 的RNA干扰 (RNAi) 疗法,显示出药物开发的前景. 克服传递挑战是扩大siRNA疗法超越肝脏用于各种疾病的关键.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 制药科学 制药科学
背景情况:
- RNA干扰 (RNAi) 是一种具有显著治疗潜力的基因调节机制.
- 最近的FDA批准强调了针对肝脏的小干扰RNA (siRNA) 药物的成功.
- 显著的挑战,特别是在交付方面,阻碍了siRNA疗法的更广泛应用.
研究的目的:
- 审查治疗siRNAs设计的关键考虑因素和未来方向.
- 强调化学,信息学和输送策略在siRNA药物开发中的作用.
- 讨论目标选择对于优化治疗结果的重要性.
主要方法:
- 关于RNAi疗法和药物开发的当前文献的综述.
- 对siRNAs的化学修饰,信息学应用和传递系统的分析.
- 讨论目标选择标准及其对治疗疗效的影响.
主要成果:
- 合成的siRNAs具有强大而持久的基因沉默能力.
- 目前的siRNA药物主要被批准用于肝脏点,限制了肝脏外应用.
- 输送仍然是推动siRNA疗法向非肝脏组织的关键瓶.
结论:
- 在siRNA设计,化学和传递方面持续创新是必不可少的.
- 整合信息学和仔细的目标选择可以提高治疗成功.
- 扩大siRNA疗法的实用性超越肝脏需要解决目前的局限性.
更多相关视频
11:58Using In Vitro and In-cell SHAPE to Investigate Small Molecule Induced Pre-mRNA Structural Changes
Published on: January 30, 2019
8.3K
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
1000
相关概念视频
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Structure-Activity Relationships and Drug Design
716
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
716
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Types of RNA
63.6K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.6K
RNA Editing
9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K
